The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses
International Journal of Molecular Sciences · 05.07.2024 · 25 (13) · 7370
DOI: 10.3390/ijms25137370 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.07.2024. Verfasst von Giulia Sibille und 7 weiteren Autor:innen. Beteiligte Einrichtung: Microbiology and Virology Unit, Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Turin, Italy. Hauptthemen laut MEDLINE: Proanthocyanidins, Antiviral Agents, SARS-CoV-2, Virus Replication. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases, Piedmont Region, University of Turin.
Abstract (Originalsprache)
The appearance of new respiratory virus infections in humans with epidemic or pandemic potential has underscored the urgent need for effective broad-spectrum antivirals (BSAs). Bioactive compounds derived from plants may provide a natural source of new BSA candidates. Here, we investigated the novel phytocomplex formulation SP4™ as a candidate direct-acting BSA against major current human respiratory viruses, including coronaviruses and influenza viruses. SP4™ inhibited the in vitro replication of SARS-CoV-2, hCoV-OC43, hCoV-229E, Influenza A and B viruses, and respiratory syncytial virus in the low-microgram range. Using hCoV-OC43 as a representative respiratory virus, most of the antiviral activity of SP4™ was observed to stem primarily from its dimeric A-type proanthocyanidin (PAC-A) component. Further investigations of the mechanistic mode of action showed SP4™ and its PAC-A-rich fraction to prevent hCoV-OC43 from attaching to target cells and exert virucidal activity. This occurred through their interaction with the spike protein of hCoV-OC43 and SARS-CoV-2, thereby interfering with spike functions and leading to the loss of virion infectivity. Overall, these findings support the further development of SP4™ as a candidate BSA of a natural origin for the prevention of human respiratory virus infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Microbiology and Virology Unit, Department of Life Sciences and Systems Biology, University of Torino, Via Accademia Albertina 13, 10123 Turin, Italy.
- Plant Physiology Unit, Department of Life Sciences and Systems Biology, University of Torino, Via Quarello 15/a, 10135 Torino, Italy.
- Department of Molecular Medicine, University of Padova, 35121 Padova, Italy.
ORCID-Profile: Giulia Sibille, Giuseppe Mannino, Ilaria Frasson, Marta Pavan, Anna Luganini, Cristiano Salata, Massimo E Maffei, Giorgio Gribaudo
Förderung
- EU funding within the MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases
- Piedmont Region
- University of Turin
- EU
- University of Torino
Zitieren
APA
Sibille, G., Mannino, G., Frasson, I., Pavan, M., Luganini, A., Salata, C., Maffei, M. E., & Gribaudo, G. (2024). The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses. International Journal of Molecular Sciences, 25(13), 7370. https://doi.org/10.3390/ijms25137370
Vancouver
Sibille G, Mannino G, Frasson I, Pavan M, Luganini A, Salata C, et al. The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses. International Journal of Molecular Sciences. 2024;25(13):7370. doi:10.3390/ijms25137370
BibTeX
@article{Sibille2024,
author = {Sibille, Giulia and Mannino, Giuseppe and Frasson, Ilaria and Pavan, Marta and Luganini, Anna and Salata, Cristiano and Maffei, Massimo E and Gribaudo, Giorgio},
title = {The Novel A-Type Proanthocyanidin-Rich Phytocomplex SP4™ Acts as a Broad-Spectrum Antiviral Agent against Human Respiratory Viruses},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {13},
pages = {7370},
doi = {10.3390/ijms25137370}
}
EUVIMED